OBJECTIVE To review the biology and the pathophysiology of uterine myomas, focus on options for management, and emphasize principles that will render the decision-making process as logical as possible. DESIGN Literature review and synthesis of the authors' experience and philosophy. RESULTS Uterine myomas are the most common solid pelvic tumors in women. There is increasing evidence that th...

Uterine myoma is a benign tumor originating from the smooth muscle of uterus. In general, uterine myomas are asymptomatic and found incidentally during ultrasound examination pregnancy. We report that 39-year-old woman with GIIP1001 admitted she was 40 weeks pregnant came complaints intermittent abdominal pain started at 04.00 in morning, getting worse 2 hours before MRS. Complaints accompanied...

Introduction: Cardiovocal hoarseness (Ortner’s syndrome) is hoarseness of voice due to recurrent laryngeal nerve involvement secondary to cardiovascular disease. Recurrent laryngeal nerve in its course (especially the left side) follows a path that brings it in close proximity to numerous structures. These structures interfere with its function by pressure or by disruption of the nerve caused b...

BACKGROUND Uterine myomas are common pelvic masses during pregnancy. The pain and rapid growth of myomas are among the most common complications during pregnancy. We evaluate management of painful cystic degeneration of myomas during pregnancy. CASE A 27-year-old primigravida had a pelvic mass. We have managed a case in which the diagnosis of cystic degeneration of uterine myomas could not be...

Massive hemoperitoneum from spontaneous bleeding of uterine myoma is an extremely rare condition, that needs urgent surgical exploration. We report a 40-year-old woman, admitted for acute onset of abdominal pain. Physical examination revealed hypovolemic shock. The hemoglobin level was of 5 g/dL. Ultrasonography revealed hemoperitoneum. Emergency surgical exploration was planned. There was hemo...

Purpose Myomas are common benign tumors in woman. Patients prefer non-invasive treatment to preserve fertility and avoid surgery. In 2004 FDA approved MRgFUS for uterine myoma. The current study examined the safety and efficacy of MRgFUS for different myomas characteristics. Methods and Materials: A total of 925 patients, aged 20-55, with symptomatic myomas underwent MRgFUS (2006-2012). Prior t...

background: leiomyomata is the most frequent gynecological neoplasm. one of the major complications of myomectomy is intrauterine adhesion (synechiae). objective: to evaluate and compare the rate and severity of synechiae formation after myomectomy by laparotomy and laparoscopy. materials and methods: in this non-randomized interventional trial, hysteroscopy was performed in all married fertile...

Background and Objectives. A new two-step hysteroscopic myomectomy carried out in the office setting and without anesthesia was feasible for the excision of submucous myomas. The objective of this study was to assess whether removal of submucous myomas from the uterine cavity after hysteroscopic laser enucleation is necessary. Methods. Between June 2009 and April 2013, all outpatients with symp...